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ABSTRACT: The self-assembly behavior and antimicrobial
activity of two designed amphiphilic peptides, R3F3 and R4F4,
containing short hydrophobic phenylalanine (F) and cationic
arginine (R) sequences, are investigated. The conformation of the
peptides was examined using circular dichroism and FTIR
spectroscopy, which show that they have a disordered secondary
structure. Concentration-dependent ﬂuorescence assays show the
presence of a critical aggregation concentration (cac) for each
peptide. Above the cac, small-angle X-ray scattering (SAXS) and
transmission electron microscopy (TEM) reveal a population of
twisted tapes for R3F3 and nanosheets for R4F4. The interaction of
the peptides with model bacterial membranes comprising mixtures of the lipids DPPG [1,2-dipalmitoyl-sn-glycero-3-
phosphoglycerol] and DPPE [1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine], was studied using SAXS and cryogenic-TEM.
Analysis of the SAXS structure factor indicates that R3F3 interacts with lipid bilayers by inducing correlation between bilayers,
whereas R4F4 interacts with the bilayers causing an increase in polydispersity of the vesicle wall thickness. Both peptides break
vesicles with a 1:3 DPPG:DPPE composition, which is close to the ratio of PG and PE lipids observed in the lipid membrane of
Pseudomonas aeruginosa, a pathogen responsible for serious infections and which has developed antimicrobial resistant strains. Both
peptides show activity against this bacterium in planktonic form. Peptide R4F4 shows particularly strong bioactivity against this
microbe, with a minimum inhibitory concentration (MIC) value in the range of concentrations where the peptide is cytocompatible.
It was further shown to have activity against other Pseudomonas species including the common plant pathogen Pseudomonas syringae.
Finally, we show that R4F4 inhibits the development of P. aeruginosa bioﬁlms. This was examined in detail and a proposed
mechanism involving binding of the signaling molecule c-di-GMP is suggested, based on circular dichroism spectroscopy studies and
Congo red assays of extracellular polysaccharides produced by the stressed bacteria. Thus, R4F4 is a promising candidate
antimicrobial peptide with activity against Pseudomonas species.
KEYWORDS: peptide, liposomes, model membranes, antimicrobial, self-assembly, SAXS
■ INTRODUCTION
The increase in prevalence of multi-antibiotic-resistant
pathogens is of great concern and has been listed by the
World Health Organization (WHO) as one of the biggest
threats to modern day healthcare, food security, and
development. There is great interest in the development of
new therapeutics to overcome this. Peptides, especially those
containing cationic residues or tryptophan, have been shown to
have great potential in this regard.1,2 Many antimicrobial
peptides have evolved naturally in species of plants and
animals, providing a strong basis to produce biocompatible
therapeutics. Peptides with the ability to self-assemble are of
interest as they may have increased in vivo stability through
increased half-life and resistance to proteolysis.
Antimicrobial peptides are thought to interact with the cell
membranes of bacteria through diﬀerent mechanisms.2 It has
been proposed that some peptides induce pore formation
where the pore is lined with peptide (the barrel-stave model),
or when the peptide causes curvature of the lipid membrane
(the toroidal pore model).3 Another mechanism involves
peptide deposition on the membrane surface (the carpet
model), which is followed by a detergent-like action that leads
to pore formation.3 Cationic peptides are able to associate with
the membrane and cause an electrical potential diﬀerence
across the membrane, inducing electroporation (the molecular
electroporation model).4
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An important class of antimicrobial peptide are those
containing L-arginine.2 L-Arginine is commonly found as an
active site residue in proteins and is common in many cell-
penetrating peptides. The antimicrobial activity of L-arginine is
due to the cationic charge of this amino acid which interacts
with anionic or zwitterionic lipid membranes, which may lead
to pore formation.5,6
Surfactant-like peptides (SLPs) are a group of peptides with
promising applications as antimicrobials. Structurally, SLPs
have a headgroup of a small sequence of charged residues and
a longer hydrophobic tail, which gives them remarkable self-
assembling properties.7−9 Recently, the self-assembly of three
SLPs, A3K, A6K, and A9K, was examined and distinct
morphologies were observed for the three peptides.10 The
antimicrobial properties were found to be dependent on the
length of the hydrophobic chain, with A9K being most active
against Escherichia coli and Staphylococcus aureus, also strongly
disrupting the structure of anionic vesicle DPPG,10 used as a
model system for bacterial cell membranes.
Our group has studied the self-assembly properties and
antimicrobial activities of several SLPs containing one or two
arginine residues. Surfactant-like peptide A6R was found to
self-assemble into nanoﬁbers, and to have antimicrobial
activity.11,12 More recently, A6R in both capped and uncapped
forms was examined. CapA6R forms nanoﬁbrils, whereas A6R
assembles into nanotapes, which preferentially interacted with
lipid POPG in POPG/POPE vesicles [POPG = 2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphoglycerol, POPE = 2-oleoyl-1-
palmitoyl-sn-glycero-3-phosphoethanolamine].13 The capped
A6R variant showed selective activity against Gram-positive
Listeria monocytogenes, and the uncapped version showed
greater antimicrobial activity against this and also E. coli and S.
aureus.13 Another surfactant-like peptide, RA3R, containing
arginine on both termini, was found to assemble into a
polyproline II helix in water, which interacted strongly with
POPG in mixed lipid vesicles.14 RA3R was found to be
particularly active against L. monocytogenes through membrane
reorganization.
Here, we examine the self-assembly behavior and antimicro-
bial activity of two SLPs with sequences RRRFFF (R3F3) and
RRRRFFFF (R4F4) (Scheme 1). These peptides comprise a
hydrophobic phenylalanine block and a block of cationic L-
arginine residues, and were designed as novel arginine-rich
SLPs containing aromatic hydrophobic blocks, incorporated to
drive self-assembly via π-stacking interactions. Recently, Silva
et al. examined the self-assembly of peptides consisting of
alternating RF motifs. The short oligopeptide [RF]4 was found
to assemble into highly ordered amyloid-like ﬁbrils above a
critical aggregation concentration.15 Further studies of [RF]n,
where n is between 1 and 5, showed an increased structural
order and cytotoxicity with increasing n.16 In another example,
Fojan et al. studied the self-assembly of RFFFR, which was
shown to self-assemble into ﬁbers stabilized by π-stacking
interactions, which further assembled into solid spheres.17
The two peptides we investigate, R3F3 and R4F4, are
architecturally diﬀerent from these previously studied RF-
containing peptides and surfactant-like peptides, as they
contain blocks of symmetric charged and hydrophobic blocks.
We ﬁrst present results on the self-assembly and
conformation of R3F3 and R4F4. We, then, examine the
interactions of these peptides with DPPG/DPPE vesicles.
DPPG (1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol), is
anionic, whereas DPPE (1,2-dipalmyitoyl-sn-glycero-3-phos-
phoethanolamine) is zwitterionic. Cationic peptides have the
ability to distinguish between human cell membranes, which
mainly contain lipids based on phosphocholine (PC), as
opposed to bacterial cell membranes, which contain signiﬁcant
quantities of PG (phosphoglyercol) and PE (phosphoethanol-
amine) lipids.13,14,18,19 Examining the interactions of the two
peptides with these bacterial membrane models enables greater
understanding of the mechanisms by which these peptides
interact with speciﬁc membrane constituents of bacteria.
Typically, more PG lipids are found in Gram-positive bacteria,
whereas PE lipids are generally more abundant in Gram-
negative bacteria.20 We study the interaction of the two
designed peptides with model lipid membranes with diﬀerent
ratios of PG/PE, to better understand antimicrobial activity.
Speciﬁcally, we examine the interactions of the peptides with
mixed lipids comprising ratios PG/PE and 3:1, 1:1, 1:3, and
1:0, in line with a previous study.19 The combination of DPPG
and DPPE was chosen due to the accessible melting
temperature Tm values, which are well separated for the two
lipids, being reported to be 41 and 63 °C, respectively.21
Finally, we examine the antibacterial activity of these
peptides against four species of bacteria, E. coli, S. aureus,
Pseudomonas aeruginosa, and Pseudomonas syringae. Since
minimal toxicity to human cells is an essential requirement
of an eﬀective peptide therapeutic, we also assay the
cytocompatibility of these peptides using a human skin
ﬁbroblast model.
Scheme 1. Structures of Peptides RRRFFF (R3F3),
RRRRFFFF (R4F4), and the Two Lipids Used in Model
Membranes, 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol
(DPPG) and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine (DPPE)
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Figure 1. Conformation and self-assembly of R3F3: (a) ﬂuorescence assay to determined cac using ANS and ThT at native pH (pH 2), (b) CD
spectra at pH values indicated, (c) FTIR spectra at pH values indicated, and (d) SAXS data with ﬁtted form factors in red.
Figure 2. Conformation and self-assembly of R4F4: (a) ﬂuorescence assay to determine cac using ANS at native pH (pH 2), (b) CD spectra at pH
values indicated, (c) FTIR spectra at pH values indicated, and (d) SAXS data with ﬁtted form factors in red.
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■ RESULTS
Self-Assembly. The critical aggregation concentration
(cac) for both R3F3 and R4F4 was determined using 8-
anilinonaphthalene-1-sulfonic acid (ANS), which is used
because its ﬂuorescence changes within a hydrophobic
environment. The cac values for R3F3 (Figure 1a) and R4F4
(Figure 2a) were found to be (0.32 ± 0.02) and (0.22 ± 0.03)
wt % respectively. There is a signiﬁcant diﬀerence in cac values,
the cac being lower for R4F4 than for R3F3, which suggests that
the cac depends not just on the balance of hydrophobic and
charged residues but is also inﬂuenced by the number of
charged residues. To further assess the critical aggregation
concentration, the amyloid-sensitive ﬂuorophore thioﬂavin T
(ThT) was used. Only R3F3 was found to bind signiﬁcantly to
ThT, indicating that it forms amyloid-like ﬁbers. As shown in
Figure 1a, the cac of R3F3 determined by ThT ﬂuorescence
assays was found to be (0.27 ± 0.03) wt %, which is consistent
within uncertainty with that detected by ANS. This suggests
that hydrophobic collapse occurs at the same concentration as
the formation of amyloid structures by R3F3.
To examine the secondary structure of R3F3 and R4F4,
circular dichroism and Fourier transform infrared spectroscopy
were conducted above the cac. The CD spectra are dominated
by electronic transitions associated with the phenylalanine side
chain. The main feature (Figures 1b and 2b) for all spectra is
the peak at 220 nm which is due to phenylalanine π-stacking
electronic transitions.22 The molar ellipticity increases when
the pH of solutions of R3F3 and R4F4 was adjusted to pH 7.
This indicates an increase in content of chiral structures. FTIR
(Figures 1c and 2c) was used to further probe secondary
structure. The data shows a peak at 1673 cm−1, which can be
assigned to vibrations of the TFA counterions bound to the
peptide.23 The peak at 1645 cm−1, characteristic of a
disordered secondary structure, is present only at native pH
for both peptides. All spectra show a peak at 1608 cm−1, which
is characteristic of arginine side chains.23,24 The peak at 1588
cm−1 can be assigned to the arginine side chain guanidinium
group symmetric stretch. The 1456 cm−1 peak can be ascribed
to −CH2 bond vibrations.25 Considering the data from both
CD and FTIR spectroscopy, we conclude that at native pH,
R3F3, and R4F4 have a disordered secondary structure.
TEM was used to image the self-assembled structure of R3F3
and R4F4 (Figure S1). Self-assembled structures were observed
for both peptides, with R3F3 forming a population of twisted
nanotapes, that are several microns long, with a width between
50 and 120 nm. The presence of nanotapes agrees with the
binding of ﬂuorescent probe ThT. R4F4 was found to assemble
into a population of large nanosheets of diﬀering sizes with
widths between 342 and 1.7 μm. These non-amyloid structures
are not expected to bind ThT, consistent with the ﬂuorescence
binding assays.
To further probe the self-assembled structures, SAXS
measurements were performed (Figures 1d and 2d) in dilute
solutions to provide form factors. These are analyzed to
provide information on the shape and dimensions of self-
assembled nanostructures. Data from peptide solutions at pH 7
Figure 3. SAXS proﬁles for diﬀerent liposome compositions (expressed in terms of ratios of DPPG/DPPE) in the presence of R3F3 or R4F4 at the
concentrations indicated: (a) DPPG vesicles alone, (b) DPPG/DPPE 3:1, (c) DPPG/DPPE 1:1, and (d) DPPG/DPPE 1:3. Bragg peaks are
numbered.
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show initial intensity decays with q−2 which indicates planar
structures. The data was ﬁtted to a bilayer Gaussian form factor
model (previously used by our group to describe the density
proﬁle across a bilayer),23,26 and a generalized Gaussian coil
form factor to account for any monomers remaining in the
solution (Tables S1 and S2) using the software SASﬁt.27 This
model ﬁts the data very well. An estimate of the length of the
peptide (assuming an antiparallel β-sheet structure) is the
number of residues multiplied by 3.4 Å.28 The approximate
length of R3F3 and R4F4 is 20 and 27 Å, respectively. The
bilayer thickness obtained from the SAXS ﬁts corresponds
approximately to these values implying that the nanosheets and
twisted tapes are one molecule thick. This suggests an
antiparallel arrangement leading to arginine-coated nano-
tapes/nanosheets (a nanosheet structure with this conﬁg-
uration was proposed for A6R).
12 From these measurements,
we conclude that the peptides form a small population of
bilayer structures, with a larger population of unaggregated
peptides. Adjustment to pH 7 increases the population of these
structures.
Interaction with Lipid Vesicles. To understand the
antimicrobial activity of R3F3 and R4F4 discussed in the
following section, which is due to interaction of the arginine
residues with lipid headgroups, we examined whether there
were any interactions between the peptides and the model
DPPG/DPPE liposomes, a system commonly used as a
bacterial membrane model.10,19 SAXS was used to probe
structure changes resulting from interaction of peptides with
lipid membranes. We examined the ratios 1:0, 1:3, 1:1, and 3:1
of DPPG/DPPE. In accordance with the phase diagrams
recorded previously,19 the samples with mixtures 1:0, 1:1, and
3:1 DPPG/DPPE are expected to be in the disordered liquid
crystal (Lα) phase at 20 °C, whereas 1:3 DPPG/DPPE is
expected to be in the Lα/Lβ coexistence region at 20 °C (where
Lβ is the ordered gel phase). PE alone is not studied because of
the shape of the lipid it forms inverted micelles with hexagonal
symmetry.14
Figure 3 shows SAXS intensity proﬁles obtained with ratios
1:0, 1:3, 1:1, and 3:1 of DPPG/DPPE at 0.5 wt % with and
without R3F3 and R4F4. For all ratios, the SAXS patterns for the
liposomes of lipids alone displayed a broad scattering peak
centered at q ∼ 0.1 Å−1, which is associated with unilamellar
vesicles.13 Figure 3 also contains the SAXS data for samples
with added peptide. A concentration of 0.08 wt % peptide was
used (data being shown for an additional concentration of 0.25
wt % for R4F4 with DPPG), since addition of 0.25 wt %
peptide caused precipitation in many samples, as seen with
previously studied peptides.13,14
In the SAXS data for 1:0 DPPG/DPPE, 0.08 wt % R3F3,
there is a small Bragg peak, with a corresponding domain
spacing d = 45.9 Å and a distortion of the broad peak shape.
This indicates some correlation between bilayers, that is,
restructuring of a proportion of vesicles into multilamellar
vesicles. Adding 0.08 wt % R4F4 to DPPG leads to a change in
the shape of the SAXS proﬁle (broadening of the form factor
extrema), and when the concentration of R4F4 is increased to
0.25 wt %, two Bragg peaks with d = 43.4 and 14.6 Å are
present. These peaks correspond to the ﬁrst- and third-order
reﬂections of a multilamellar structure, indicating that
restructuring of most liposomes into multilamellar vesicles
occurs in the presence of R4F4 at this concentration, indicating
peptide-induced lipid restructuring. R3F3 was not examined at
this concentration due to precipitation of the sample.
Figure 4. Cryo-TEM images of vesicles with and without peptide: (a) 0.5 wt % DPPG/DPPE 1:3, (b) 0.5 wt % DPPG/DPPE 1:3 + 0.08 wt %
R3F3, (c) 0.5 wt % DPPG/DPPE 1:3 + 0.08 wt % R4F4, (d) 0.5 wt % DPPG, (e) 0.5 wt % DPPG + 0.08 wt % R3F3, and (f) 0.5 wt % DPPG + 0.08
wt % R4F4.
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For the lipid mixture 3:1 DPPG/DPPE, no Bragg peak was
observed in the SAXS proﬁles in the presence of either peptide,
indeed the form factor resembles that for the corresponding
mixed liposome, with again only some broadening of form
factor features (and a shift to higher q) particularly in the
presence of R4F4. For R3F3 combined with 1:1 DPPG:DPPE,
there is again a broadening in the features in the SAXS curve.
However, for R4F4, two Bragg peaks are noted with
corresponding spacings d = 96.0 and 68.2 Å, which is
approximately a 1: √2 ratio suggesting cubic symmetry,
although the presence of two coexisting lamellar structures
cannot be excluded in the absence of higher order Bragg
reﬂections. This feature is not observed for R3F3.
Considering the SAXS data for the samples containing most
DPPE (1:3 DPPG/DPPE), the liposome form factor is lost
upon addition of either peptide, this being replaced with form
factor proﬁles with a shape dominated at low q by scattering
from the peptides alone (Figures 1d and 2d), especially for
R4F4, although there is a Bragg peak for R3F3, showing some
multilamellar vesicles are still present. Cryo-TEM images of
samples prepared with lipids at this ratio show that R3F3 causes
a change in morphology of liposomes, seen by the appearance
of rougher looking surfaces (Figure 4b). Cryo-TEM images of
samples with this lipid composition in the presence of R4F4
show that the peptide induces complete disruption of liposome
formation, in agreement with conclusions from the SAXS data
(Figure 4c). The Cryo-TEM image for vesicles of DPPG
(Figure 4d) shows that vesicles are generally larger when
exposed to R3F3 with some ﬁbers (presumably peptide) also
present (Figure 4e), whereas with R4F4, the vesicles are more
swollen and, moreover, are much more angular in shape and
have a multilamellar structure (Figure 4f). This is consistent
with the SAXS data shown in Figure 3a.
Circular dichroism spectroscopy is often also used to
examine the interactions of lipid membranes with pepti-
des.13,14,29 In some instances, peptide secondary structure is
shown to be inﬂuenced in the presence of lipid membranes
which can induce the formation of more ordered secondary
structure. This moreover gives information about whether the
peptide interacts with the lipid as a monomer or as a self-
assembled structure. Figure S2 shows the circular dichroism
spectra for the mixtures of the two peptides with diﬀerent
composition lipid mixtures. Because of presence of the broad
maximum around 220 nm in the spectra, it is concluded that
the peptides interact with the lipids in a monomeric form.
Before investigating the potential antimicrobial activity of
R3F3 and R4F4, it is desirable to assay cytocompatibility, to
determine the concentration range of peptides over which
viability of human cells is retained. We therefore performed
cytotoxicity assessments using the MTT assay on 161br human
skin ﬁbroblasts (Figure S3). The IC50 of R4F4 was calculated to
be 2.15 mM (or 2.64 mg/mL or 0.264 wt %). Interestingly,
this is in the error range of the cac value determined for R4F4
(Figure 1a) implying that the self-assembly into nanosheet
structures correlates to the onset of increased toxicity. The
IC50 of R4F4 is higher than the previously studied [RF]4
peptide, which has an IC50 value of less than 1 mM, meaning
that R4F4 is less cytotoxic. Clearly, sequence has a signiﬁcant
eﬀect on the cytotoxicity of these compositionally identical
peptides. The IC50 of R3F3 was found to be 4.31 mM (4 mg/
mL or 0.4 wt %), the maximum concentration used in the
concentration series and above the cac of this peptide. The
ﬁnding that an increased number of residues leads to increased
toxicity agrees with studies conducted with [RF]n repeating
peptides,16 although R4F4 is signiﬁcantly less cytotoxic than its
compositional homologue RFRFRFRF.
Figure 5. Activity of R3F3 and R4F4 against several strains of bacteria, (a) E. coli, (b) S. aureus, and (c) P. aeruginosa, and (d) MIC determination for
R4F4 with P. aeruginosa. *= p < 0.05, ** = p < 0.01, and ***p < 0.001.
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Having determined conditions where viability of human
ﬁbroblasts in the presence of these peptides is acceptable, we
then studied their antimicrobial activity. Compounds that are
active against bacteria have either inhibitory or bactericidal
properties.30 Inhibitory compounds are less likely to cause
bacterial resistance but are more susceptible to the innate
immune system and antibiotics. Bactericidal compounds are
useful for ﬁghting bacterial infections but can increase the
resistance of bacteria. Both activities are valuable for diﬀerent
purposes. To examine whether R3F3 and R4F4 are bactericidal,
the two peptides were inoculated with several strains of
bacteria for 24 h. Figure 5 shows the antimicrobial activity of
these peptides against Gram-positive S. aureus and two Gram-
negative bacteria, one strain of P. aeruginosa (PA01) and one of
E. coli (K12). A concentration of 0.05 wt % was selected, based
upon the viability of human skin ﬁbroblasts at this
concentration, which was shown to be 77% and 81% for
R3F3 and R4F4, respectively (Figure S3). The antimicrobial
activity data indicate that R3F3 shows no eﬀect on any of these
bacteria; however, R4F4 causes a small, not statistically
signiﬁcant, reduction of 1 order of magnitude in colony
forming units/milliliter (CFU/mL) of E. coli (K12) after 24 h.
This eﬀect, however, is not seen for the clinically relevant E.
coli (0157) strain (Figure S4). Both peptides showed no
activity against S. aureus, in contrast to previously studied
arginine-rich peptides,11,14 although this could be due to the
lower concentrations used. Interestingly, both peptides showed
a strong antimicrobial eﬀect against P. aeruginosa (Figure 5c),
with a 3.2 log reduction in CFU/mL upon addition of R3F3,
and complete death of the strain after 2 h on exposure to 0.05
wt % R4F4 (Figure 5c). To investigate this further, a series of
concentrations of R3F3 (Figure S5) and R4F4 (Figure 5d) were
examined to locate any MIC. The data indicate that R3F3 does
not have an MIC below 0.1 wt %, and R4F4 has a MIC value
between 0.045 and 0.05 wt % for P. aeruginosa.
To further understand the speciﬁcity of these peptides
against Pseudomonas bacteria, the antibacterial activity of the
peptides against four other species was examined (Figure S6).
Since R4F4 is particularly active against Pseudomonas species,
data were obtained for an additional three species. Data for
Pseudomonas putida, Pseudomonas agarici, and Pseudomonas
f luorescens are shown in Figure S6a−c, and this shows that all
bacteria displayed an initial die oﬀ when exposed to R4F4, but
interestingly, P. f luorescens shows some recovery in bacterial
colony counts after 24 h, perhaps because the bacteria are able
to metabolize the peptide, however further studies would be
needed to understand this eﬀect. There is also a signiﬁcant (log
2.6) reduction in CFU/mL of plant pathogen P. syringae when
exposed to R3F3 and a complete bacterial kill when exposed to
R4F4, similar to the eﬀects seen with P. aeruginosa after 2 h of
exposure. The MIC concentration is ∼0.001 wt % for P.
syringae, which is approximately 50× lower than that for P.
aeruginosa. Our data suggests that R4F4 is selectively active
against speciﬁc Pseudomonas species.
Finally, we examined whether our peptides can prevent
bioﬁlm formation of P. aeruginosa, which is a major problem in
infections, in particular those of the respiratory tract. An
important regulator of bioﬁlm formation in P. aeruginosa is the
second messenger signaling molecule bis(3′5′)-cyclic dimeric
guanosine monophosphate (c-di-GMP).31−33 High levels of c-
di-GMP in P. aeruginosa are associated with the formation of
bioﬁlms, which leads to virulence and persistence of bacteria in
hosts. Compounds that can reduce and prevent bioﬁlm
formation by targeting c-di-GMP are, therefore, attracting
Figure 6. Bioﬁlm assay results: (a) Eﬀect of peptides on bioﬁlm formation after 18 h using a crystal violet assay, (b) images of vials showing crystal
violet stain left by bioﬁlms at the air−water interface, after removal of the aqueous phase, (c) Congo red assay, measuring amount of polysaccharide
produced by bacteria, at the peptide concentrations indicated, and (d) Congo red staining vials, showing ﬂocculation of the bacteria at the bottom
of the tube as opposed to the sides where there is growth.
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attention. We ﬁrst examined whether R3F3 and R4F4 inhibit
bioﬁlm growth formation and then examined interactions of
these peptides with c-di-GMP. Crystal violet was used to assay
bioﬁlm formation, this cationic dye binding to anionic
polysaccharides in the bioﬁlm.34 The assay results (Figure
6a) show that R4F4 causes a reduction of bioﬁlm formation in
two strains of P. aeruginosa, PA01 and ATCC-12600. At a
concentration 0.05 wt % of R3F3, we observe 84% survivability
of bioﬁlm (Figure S7), whereas R4F4 signiﬁcantly reduces
bioﬁlm viability to 37% of P. aeruginosa strain PA01 and 33%
for strain ATCC-12600 (Figure 6a). Figure 6b shows images of
vials showing the Crystal violet taken up by bioﬁlms formed at
the air−water interface, after removal of the aqueous phase.
The residual purple coloration of the vial surfaces is due to dye
taken up by bacteria in planktonic form.
We used a series of biophysical techniques to observe the
interaction of both peptides with ci-d-GMP, including SAXS,
CD, and TEM. At concentrations of 100 μM or more, c-di-
GMP exists in equilibrium with its homodimer.33 Interestingly,
the CD spectra of R4F4 and R3F3 show that c-di-GMP causes a
strong increase in molar ellipticity (Figure S8a) at a 255 nm
maximum for R3F3 and a slight red-shifted maximum of R4F4 of
259 nm and an increase in negative ellipticity at the minimum
at 281 nm for R3F3 and 284 nm for R4F4, which are due to the
stacking of the four guanine rings present in dimers of c-di-
GMP, showing that addition of the peptides stabilizes the
homodimer.33 The red shifting of peak positions for R4F4 is
evidence of altered π-stacking in the complex between c-di-
GMP and R4F4, which is not observed for the c-di-GMP
complex with R3F3. TEM images for c-di-GMP with R3F3 show
the formation of nanosheets (Figure S8c). In contrast, the
TEM image for c-di-GMP with R4F4 shows the formation of a
ﬁbrous network structure (Figure S8e). Diﬀerences in structure
also change the slope of the SAXS proﬁles in the low q region
(Figure S8b,d), I ∼ q−n. The slope of the low q intensity for c-
di-GMP alone is n = 0.8 consistent with locally extended
structures. Upon addition of R3F3, the slope changes to n = 1.8
which suggests the formation of layered structures, such as
bilayers as seen in the TEM images. The peptide alone has a
SAXS proﬁle with n = 3.5. For R4F4, the slope changes to n =
4.2, suggesting the presence of compact globular structures.
Congo red staining can be used to quantify the amount of
polysaccharides produced by bacteria.35 This has been used as
an indirect measurement of c-di-GMP levels since these are
correlated to polysaccharide expression.35 Congo red binds to
polysaccharides resulting in a decreased optical density (OD)
when polysaccharide matrices are formed by the bacteria.35
When adding R4F4 to P. aeruginosa, we observe a decrease in
optical density of the supernatant (Figure 6c). This indicates
enhanced bioﬁlm growth, however, it was observed that, from
0.00613 to 0.025 wt %, there was a precipitate at the bottom of
the tube, and some ﬁlm growth occurred at the interface of the
tube between the air and the solution (Figure 6d). P.
aeruginosa is a motile organism, therefore is expected to form
a bioﬁlm at the interface.36 At 0.05 wt % (0.5 mg/mL), a
concentration that is the above the MIC in water and for which
37% bioﬁlm viability is observed (Figure 6a), there is no
biomass on the side of the tube, but there is a deposit on the
bottom of the tube (Figure 6d). P. aeruginosa has a mucoidal
phenotype, which means it can form a polysaccharide capsule
around itself in response to stressed conditions.37 Therefore,
we conclude that the reduction in the OD is due to stressed
bacteria producing polysaccharides as part of the stress
response.
■ CONCLUSIONS
The two “blocky” surfactant-like peptides R3F3 and R4F4 are
both able to self-assemble in aqueous solution at concen-
trations in excess of critical values, obtained from ﬂuorescence
probe assays. The cac = 0.3 wt % (≡ 3.2 mM) for R3F3 is
higher than that previously obtained for the compositional
homologue peptide RFRFRF, for which the cac = 2.3 mM.16
On the other hand, the cac = 0.22 wt % (≡ 1.8 mM) for R4F4
is signiﬁcantly higher than that previously reported for the
compositional homologue RFRFRFRF, for which the cac =
0.34 mM.16 This shows a signiﬁcant inﬂuence of sequence on
aggregation propensity. In addition, the nanostructure that self-
assembles is distinct, since R3F3 forms a population of twisted
nanotape structures whereas RFRFRF adopts a globular
morphology. In the case of the longer peptides, nanosheets
are formed by R4F4, whereas RFRFRFRF adopts a nanoﬁber
morphology. The self-assembly of these peptides is likely
driven by π-stacking interactions. This is supported by the
observation in the CD spectra that the molar ellipticity of the
220 nm peak due to phenylalanine π-stacking increases from
native pH to pH 7, as shown in Figures 1b and 2b.
The CD and FTIR spectra measured for R3F3 and R4F4
show that, even above the cac, these peptides do not adopt
well-deﬁned secondary structures, although there are π-
stacking interactions. Furthermore, the SAXS intensity proﬁles
suggest a signiﬁcant component of unaggregated peptides in
solution, also above the cac. Combined with the relatively high
cac values (compared to typical surfactant-like peptides, such
as A9R
38 or lipidated peptides), this indicates that R3F3 and
R4F4 have a weak aggregation propensity. This may be
beneﬁcial in terms of the observed antimicrobial activity, which
is observed at concentrations an order of magnitude below the
cac.
We found that both peptides have antimicrobial activity
against Pseudomonas species, with R4F4 particularly active,
killing all colony forming units of P. aeruginosa in planktonic
form at 0.05 wt % (0.5 mg/mL). At this concentration, the
cytotoxicity to human cells (ﬁbroblast model) is relatively low.
This peptide has a MIC of 0.045 wt % (0.45 mg/mL, 0.37
mM). This peptide also showed activity against other
Pseudomonas species, in particular P. syringae, which is a
widespread plant pathogen. We propose that the antimicrobial
activity against Pseudomonas in planktonic form may be due to
disruption of the bacterial lipid membrane, which contains
∼21% PG lipids and 60% PE lipids (the remainder being
cardiolipin).39,40 This 1:3 ratio of PG: PE corresponds to the
composition where model vesicle membrane disruption is
observed by SAXS and cryo-TEM (Figures 3 and 4) and this
composition of vesicle has been used in prior studies of
cationic antimicrobial peptide activity.40
We were then led to further examine the activity of lead
candidate peptide R4F4 against Pseudomonas bioﬁlms and a
signiﬁcant reduction in bioﬁlm viability was observed through
Crystal violet assays although bioﬁlm formation was not
completely inhibited. Since c-di-GMP is known to be an
important signaling molecule involved in Pseudomonas bioﬁlm
formation, we then examined the interaction of the two
peptides with this nucleotide. Circular dichroism conﬁrmed an
interaction with the peptides which stabilizes the homodimer
form of c-di-GMP and in the case of R4F4, modiﬁcation of π-
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stacking interactions was observed. These observations point
to a possible role of these arginine-rich peptides as binders of
c-di-GMP, and this is a possible mechanism of bioﬁlm
inhibition. The arginine guanidinium group is known to bind
c-di-GMP through electrostatic interactions and hydrogen
bonding, and this was further probed using Congo red staining
of polysaccharides, which were overexpressed by bacteria
exposed to the antimicrobial activity of R4F4.
In summary, R4F4 is a promising candidate peptide with
pronounced antimicrobial activity against Pseudomonas species.
Although R3F3 has some activity against Pseudomonas
aeruginosa, the increased molecular weight of R4F4 seems to
confer higher activity. It would be expected that longer diblock
peptides would potentially have higher antimicrobial activity,
due to the increased cationic charge. However, this increased
charge might result in increased toxicity to human cells, thus
future work could focus on ﬁnding an optimum length of
peptide with a balance of cytocompatibility, and antimicrobial
activity. Peptide R4F4 is more active against Pseudomonas
species than RA6R and RA9R studied in our previous work.
28
Also promising is the fact that the speciﬁc activity against
Pseudomonas species is likely to slow antimicrobial resistance to
the peptide because wide spectrum actives often develop
resistance faster.
Further work could explore chemical modiﬁcation to
enhance the activity of R4F4 against bioﬁlm formation and c-
di-GMP binding capacity, along with other modiﬁcations, such
as insertion of protecting groups/lipidation/use of D-amino
acids or other non-natural residues, to enhance stability in vivo
for potential future application.
■ MATERIALS AND METHODS
Materials. R3F3 and R4F4 were synthesized by Peptide Synthetics
(Fareham, UK). Purity was determined by HPLC, and for R3F3 was
found to be 97.83%, the molar mass from ESI-MS was Mw = 928.089
g mol−1. The purity of R4F4 was 97.98%, and the molar mass from
ESI-MS was Mw= 1231.452 g mol
−1.
Sample Preparation. Samples of R3F3 and R4F4 were dissolved in
water. The native pH was found to be 2.22 and 2.28, respectively.
Adjustment of pH to pH 7.0 was done using 0.5 M NaOH.
Fluorescence Assays. The critical aggregation concentrations
(cac) of R3F3 and R4F4 were determined using ﬂuorescence
spectroscopy. Fluorescence spectra were recorded with a Varian
Cary Eclipse ﬂuorescence spectrometer with samples in 4 mm inner
width quartz cuvettes. ANS (8-anilinonaphthalene-1-sulfonic acid)
was used to probe the aggregation as a probe that is sensitive to
hydrophobic environments making it suitable to locate the cac.41 ANS
assays were performed using a 66.8 μM ANS solution (1 mg of ANS
dissolved in 50 mL water and sonicated for 30 min) to solubilize R3F3
and R4F4. Fluorescence spectra were recorded between 400 and 650
nm (λex= 356 nm). Additionally, ThT was used to determine the cac
of R3F3, as it is sensitive to the formation of amyloid ﬁbrils at the
cac.42 ThT assays were performed using 5.0 × 10−3 wt % solution to
solubilize the peptide. Spectra were recorded between 460 and 600
nm (λex= 440 nm).
Circular Dichroism (CD). CD spectra were recorded using a
Chirascan spectropolarimeter (Applied Photophysics, UK) in the
wavelength range 180−260 nm (or 340 nm for samples with c-di-
GMP). Samples 1 wt % of R3F3 and R4F4 in pure H2O at native pH
and pH 7 were pipetted into a quartz plate cell with 0.1 mm path
length. Data with absorbance less than 2 only are reported.
Measurements were recorded with a 0.5 nm bandwidth, 1 mm step
and 1 s collection time per point. The CD signal for the background
solution was subtracted from the CD signal of the sample, and molar
ellipticity was calculated.
Fourier Transform Infrared Spectroscopy (FTIR). Spectra were
recorded using a Thermo Scientiﬁc Nicolet iS5 instrument equipped
with a DTGS detector, with a Specac Pearl liquid cell (sample
contained between ﬁxed CaF2 plates). Aliquots 80 μL of 1 wt % R3F3
and R4F4 at native and pH 12 dissolved in D2O were prepared and
added into the liquid cell. Spectra were scanned 128 times over the
range 900−4000 cm−1
Transmission Electron Microscopy (TEM). Imaging was
performed using a JEOL 2100Plus TEM microscope operated at
200 kV. Droplets of sample were placed on Cu grids coated with a
carbon ﬁlm (Agar Scientiﬁc, UK), stained with uranyl acetate (1 wt
%) (Sigma-Aldrich, UK) and dried. Specimens were then loaded into
the microscope.
Cryo-TEM. Vitriﬁed specimens were prepared using an automated
FEI Vitrobot device using Quantifoil 3.5/1 holey carbon copper grids
with a hole size of 3.5 μm. Prior to use, grids were plasma cleaned
using a Gatan Solarus 9500 plasma cleaner and then transferred into
the environmental chamber of a FEI Vitrobot at room temperature
and 100% humidity. Thereafter, sample solution was applied onto the
grid, and it was blotted twice for 5 s and then vitriﬁed in a 1/1 mixture
of liquid ethane and propane at a temperature −180 °C. The grids
with vitriﬁed sample solution were maintained at liquid nitrogen
temperature and then cryo-transferred to the microscope. Imaging
was carried out using a ﬁeld emission cryo-electron microscope
(JEOL JEM-3200FSC) operating at 200 kV. Images were taken in
bright ﬁeld mode and using zero loss energy ﬁltering (Ω type) with a
slit width of 20 eV. Micrographs were recorded using a Gatan
Ultrascan 4000 CCD camera. Specimen temperature was maintained
at −187 °C during the imaging.
Liposome Preparation. Liposomes were prepared using the thin-
layer hydration method. Weighed quantities of DPPG and DPPE were
prepared by dissolution in chloroform, and thin lipid ﬁlms were
prepared by drying the lipids under a stream of nitrogen gas. Films
were then placed under vacuum for 2 h to remove any remaining
organic solvent. After this, lipids were resuspended in water to a ﬁnal
concentration of 0.5 wt % lipid, heated above their Tm and vortexed
for 5 min. Liposome mixtures were then left to equilibrate before
experiments. DPPG/DPPE vesicles were prepared using this method
at diﬀerent molar ratios of 1:3, 1:1, 3:1, and 1:0 DPPG/DPPE. To
obtain peptide/lipid mixtures, resuspended lipids were added to
peptide powders to make up a 0.08 wt % concentration of peptide,
heated above the Tm and vortexed for 5 min, then left to equilibrate.
Small-Angle X-ray Scattering. Solution small-angle X-ray
scattering (SAXS) data was collected on the bioSAXS beamline
B21, at Diamond Light Source, Harwell, United Kingdom and
beamline ID02 of the European Synchrotron Radiation Facility
(ESRF), Grenoble France. On beamline B21, samples of 1 wt % R3F3
and 1 wt % R4F4 were loaded into PCR tubes in an automated sample
changer. The samples were then delivered into a temperature-
controlled quartz capillary and exposed for 1s, acquiring 30 frames at
20 °C. Data was collected using a Pilatus Dectris 2 M detector with a
3.9 m sample−detector distance and X-ray wavelength λ = 1.0 Å.
Background was manually subtracted using ScÅtter. Form factor
modeling was done using SASﬁt.
At ID02, samples were loaded into a glass capillary (internal radius
= 2 mm) using a syringe. The beamline operated with an X-ray
wavelength λ = 1.0 Å. 2D data was collected using a Rayonix MX170
detector, with a 1.474 m sample−detector distance.
Cell Viability Assays. The cytotoxicity of both R3F3 and R4F4 was
examined. In vitro cell culture was conducted using 161Br (European
Collection of Authenticated Cell Cultures, ECACC) cells, a human
skin ﬁbroblast cell line. Cells were cultured in EMEM (Eagle’s
minimum essential medium), with 2 mM glutamine, enriched with
15% fetal bovine serum (FBS) and 1% nonessential amino acids
(NEAA). Cells were maintained in a humidiﬁed atmosphere of 37 °C,
5% CO2.
Potential cytotoxicity eﬀects were examined using the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.
The peptides were dissolved in complete media. Cells were seeded
into a 96-well plate at 4 × 104 cells/mL and allowed to adhere for 24
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h in 100 μL complete medium. After this, 100 μL of either complete
media and/or peptide solution was added, to give either control
solution, or solutions of peptide between the concentrations of
0.0625−4 mg/mL.
Cells were incubated for 67 h. After this, 20 μL MTT (5 mg/mL, in
PBS) was added to each well plate and allowed to incubate for 5 h.
After a further 5 h (72 h total), the solution was removed from the
wells and replaced with 100 μL of DMSO per well, which dissolves
the formazan crystals. Plates were incubated for 30 min, and then
analyzed using a UV microplate reader (λ = 570 nm). Results are
reported as a percentage cell viability compared to control
(untreated) values, and ﬁtted to a sigmoidal function using Origin
Lab as a guide to the eye.
Antimicrobial Studies. The antimicrobial assays were performed
with three types of bacteria which cause disease in humans, two being
Gram-negative, Escherichia coli (K12) and Pseudomonas aeruginosa
(PA01), and one being Gram-positive, Staphylococcus aureus (8325-
4). Plant bacteria species P. syringae, P. putida, P. agarici, and P.
f luorcences were also used to examine speciﬁcity against Pseudomonas
species. Stock cultures were stored in −80 °C in 7% (v/v) DMSO.
Prior to experiments, samples of all human bacteria were streaked out
onto LB (Lysogeny Broth) agar and grown overnight at 37 °C,
whereas the plant bacteria were grown overnight at 27 °C.
Bacterial Survival Assays. To examine whether the peptides were
bactericidal, one colony from streaked plates was transferred into 7
mL of sterile lysogeny broth (LB), and grown overnight at 37 °C
under agitation at 150 rev/min, on an orbital shaker, and these
cultures were used for ongoing experiments. Cultures were then
transferred into a 15 mL Falcon tube and cells were harvested by
centrifugation at 9000 rpm at 4 °C for 10 min. The supernatant was
discarded, and the pellet was resuspended in 1.5 mL of ice-chilled PBS
(phosphate buﬀered saline).
After this, 30 μL of this solution was transferred into 300 μL of 0.5
mg/mL (or 0.05 wt %) of R3F3 or R4F4, in sterile water or control
solutions of 300 μL of sterile water. Solutions were then vortexed for
5 s, and three 20 μL samples were taken at times 0, 120, and 1440
min. These samples were then serially diluted in PBS, and 10 μL of
each dilution was platted onto LB agar and incubated at 37 °C
overnight before colony counting.
Bioﬁlm Assays. To form a bioﬁlm, Pseudomonas aeruginosa PA01
and ATCC2363 strains were grown overnight in LB media. Following
this, the culture was diluted 1:100 in M63 minimal medium
supplemented with arginine and magnesium sulfate, with and without
R3F3 or R4F4, with four technical replicates. After this the plate was
incubated for 4−24 h.
Following incubation, the supernatant was discarded and then
gently washed in water several times to decrease background staining.
After this, 125 μL of 0.1 wt % crystal violet solution was added to each
well of the microtiter plate and incubated for 10 min. Following this,
the plate was washed several times and left to dry overnight.
Next, 125 μL of 30% acetic acid in water was added, to solubilize
the bioﬁlm, and the plate was incubated for further 10 min to allow
solubilization. Absorbance was measured using a plate reader at 550
nm. Anova and Tukey were used to assess statistical signiﬁcance.
Indirect Measurements of c-di-GMP Using Congo Red.
Pseudomonas aeruginosa PA01 was grown overnight in LB media.
After this, the culture was diluted 1:100 in 1 mL of M63 minimal
medium supplemented with 0.4% L-arginine and 1 mM magnesium
sulfate, with 40 μg/mL Congo red with and without R4F4.Control
solutions were also prepared using the described medium above with
no bacterial cells present. Congo red provides an indirect measure of
c-di-GMP levels as it binds to the matrix of the bioﬁlm, production of
which is correlated to c-di-GMP levels.35 Samples were shaken at 200
rpm overnight in a shaking incubator. After this, 200 μL of
supernatant was added in triplicate to a 96 well place, and measured
using a plate reader at 490 nm. Results are reported as (control
solution OD − bacteria containing solution OD). Student’s t tests
were used to assess signiﬁcance.
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